Hawaii SB226 regulates step therapy protocols for prescription drugs, ensuring fair and transparent processes for exceptions.

Hawaii SB226 mandates that step therapy protocols for prescription drugs be based on clinical practice guidelines. These guidelines must be developed by multidisciplinary panels of experts, ensuring they are free from conflicts of interest. Patients and their health care providers must have access to a clear process for requesting exceptions to these protocols. Insurers and utilization review organizations must make determinations on these requests within specific timeframes, with expedited processes for urgent cases.

Hawaii SB226 regulates step therapy protocols for prescription drugs, ensuring fair and transparent processes for exceptions.

Hawaii SB226 mandates that step therapy protocols for prescription drugs be based on clinical practice guidelines. These guidelines must be developed by multidisciplinary panels of experts, ensuring they are free from conflicts of interest. Patients and their health care providers must have access to a clear process for requesting exceptions to these protocols. Insurers and utilization review organizations must make determinations on these requests within specific timeframes, with expedited processes for urgent cases.